CRISPR-CAS9 in medicine, the saga continues

被引：0
|
作者：
Becu-Villalobos, Damasia [1 ]
机构：
[1] Consejo Nacl Invest Cient & Tecn, IBYME, Buenos Aires, DF, Argentina
来源：
MEDICINA-BUENOS AIRES | 2019年 / 79卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：522 / 523
页数：2
相关论文
共 50 条
  • [1] CRISPR-Cas9: A cornerstone for the evolution of precision medicine
    Razzouk, Sleiman
    [J]. ANNALS OF HUMAN GENETICS, 2018, 82 (06) : 331 - 357
  • [2] Progress and Perspective of CRISPR-Cas9 Technology in Translational Medicine
    Zheng, Ruixuan
    Zhang, Lexiang
    Parvin, Rokshana
    Su, Lihuang
    Chi, Junjie
    Shi, Keqing
    Ye, Fangfu
    Huang, Xiaoying
    [J]. ADVANCED SCIENCE, 2023, 10 (25)
  • [3] CRISPR-Cas9 Genome Engineering: Trends in Medicine and Health
    Zaib, Sumera
    Saleem, Mushtaq A.
    Khan, Imtiaz
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2022, 22 (03) : 410 - 421
  • [4] The MyLO CRISPR-Cas9 toolkit: a markerless yeast localization and overexpression CRISPR-Cas9 toolkit
    Bean, Bjorn D. M.
    Whiteway, Malcolm
    Martin, Vincent J. J.
    [J]. G3-GENES GENOMES GENETICS, 2022, 12 (08):
  • [5] Engineering Genes with CRISPR-Cas9
    Luo, Michelle L.
    Beisel, Chase L.
    [J]. CHEMICAL ENGINEERING PROGRESS, 2016, 112 (09) : 36 - 41
  • [6] Putting the brakes on CRISPR-Cas9
    Todorovic, Vesna
    [J]. NATURE METHODS, 2017, 14 (02) : 108 - 108
  • [7] CRISPR-Cas9: a world first?
    不详
    [J]. LANCET, 2018, 392 (10163): : 2413 - 2413
  • [8] Nanoparticles for CRISPR-Cas9 delivery
    Glass, Zachary
    Li, Yamin
    Xu, Qiaobing
    [J]. NATURE BIOMEDICAL ENGINEERING, 2017, 1 (11): : 854 - 855
  • [9] Protein Inhibitors of CRISPR-Cas9
    Bondy-Denomy, Joseph
    [J]. ACS CHEMICAL BIOLOGY, 2018, 13 (02) : 417 - 423
  • [10] The invisible dance of CRISPR-Cas9
    Palermo, Giulia
    Ricci, Clarisse G.
    McCammon, J. Andrew
    [J]. PHYSICS TODAY, 2019, 72 (04) : 30 - 36
12345